Neurovascular Catheters Market By Product Type (Aneurysm Coiling Catheters, Thrombectomy Catheters, Microcatheters, Diagnostic Catheters, Access Catheters), By Material Type (Polyurethane, Silicone, Stainless Steel), By Application (Cerebral Aneurysm, Stroke, Carotid Artery Disease, Intracranial Hemorrhage, Other Neurovascular Diseases), By End-User Industry (Power Generation, Oil & Gas, Manufacturing, Construction, Automotive, Chemical), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Neurovascular Catheters Market was valued at USD 5.5 Billion in 2024-e and will surpass USD 9.2 Billion by 2030; growing at a CAGR of 8.9% during 2025-2030.

The neurovascular catheters market is driven by the increasing prevalence of neurovascular diseases such as aneurysms, strokes, and carotid artery diseases. Neurovascular catheters are critical devices used in the treatment of these conditions, enabling minimally invasive surgeries to prevent further damage to the brain and improve patient outcomes. The market has grown significantly due to technological advancements in catheter design, a rising geriatric population, and an increasing number of endovascular procedures performed globally. As the healthcare industry continues to focus on reducing healthcare costs while improving the quality of care, the demand for these devices is expected to rise, creating a competitive and expanding market landscape.

Aneurysm Coiling Catheters Segment is Largest Owing to Increased Prevalence of Cerebral Aneurysms

The aneurysm coiling catheters segment dominates the neurovascular catheters market owing to the high prevalence of cerebral aneurysms and the growing adoption of minimally invasive procedures. Aneurysms, particularly in the cerebral arteries, are a significant cause of stroke and death, driving demand for procedures like coiling to treat and prevent the rupture of these aneurysms. Aneurysm coiling catheters allow physicians to place coils into the aneurysm, promoting clotting and reducing the risk of rupture. This technique is less invasive compared to traditional surgery, which has contributed to the increasing preference for aneurysm coiling as a treatment method.

The market for aneurysm coiling catheters is also supported by advancements in catheter technology, including the development of specialized catheters that offer better flexibility, durability, and precision. As more hospitals adopt advanced neurovascular treatments, the growth of this segment will continue to be strong. The global focus on improving the treatment outcomes for patients with cerebral aneurysms has positioned this subsegment as the largest in the market.

Polyurethane Material Segment is Fastest Growing Due to Increased Demand for Flexible Catheters

Among the material types used in neurovascular catheters, the polyurethane segment is the fastest growing. Polyurethane offers superior flexibility, biocompatibility, and strength, making it an ideal material for neurovascular catheters. It allows for smoother catheter insertion and better navigation within the delicate vasculature of the brain. As the demand for minimally invasive procedures increases, especially for complex surgeries such as thrombectomy and aneurysm coiling, the need for high-performance catheters made from materials like polyurethane is expected to grow rapidly.

The versatility of polyurethane in producing catheters with varying stiffness levels and lengths has made it a preferred choice for manufacturers. Additionally, its ability to withstand long periods in the human body without degradation ensures the durability of the devices. With ongoing advancements in materials science and an increasing focus on reducing the risks associated with neurovascular procedures, the polyurethane material segment will continue to experience strong growth.

Cerebral Aneurysm Application is Largest Due to High Incidence Rates

The cerebral aneurysm application is the largest in the neurovascular catheters market, driven by the high incidence rates of cerebral aneurysms globally. Cerebral aneurysms occur when there is a weak spot in the blood vessel wall in the brain, which can lead to life-threatening complications such as hemorrhagic strokes if left untreated. Early detection and intervention through procedures like coiling or stenting are critical in preventing rupture, leading to an increased demand for neurovascular catheters designed for aneurysm treatment.

Technological innovations such as more precise imaging and advanced catheter designs are enabling physicians to treat aneurysms more effectively and with less risk to the patient. As the aging population increases, the incidence of aneurysms is expected to rise, thereby driving demand for neurovascular treatments and catheters. With a focus on improving outcomes for patients with cerebrovascular diseases, the cerebral aneurysm application remains the largest contributor to the market.

Hospitals End-User Segment is Largest Owing to High Procedure Volume

The hospitals segment is the largest end-user in the neurovascular catheters market, accounting for a significant share of the demand. Hospitals are the primary setting for complex neurovascular procedures due to the availability of advanced medical technologies, expert neurosurgeons, and critical care units. These institutions are equipped to handle a wide range of neurovascular treatments, including the management of stroke, aneurysm, and other cerebrovascular diseases, which require the use of specialized neurovascular catheters.

Furthermore, hospitals benefit from economies of scale, offering a higher volume of procedures and a greater need for neurovascular devices. The integration of innovative catheter technologies in hospitals allows for more efficient treatments and better outcomes, making hospitals the dominant segment in the neurovascular catheters market. As hospitals continue to improve their capabilities in neurovascular care, this segment is expected to maintain its leadership in the market.

North America Region is Largest Owing to Advanced Healthcare Infrastructure

The North America region holds the largest share of the neurovascular catheters market, primarily due to the advanced healthcare infrastructure, high prevalence of neurovascular diseases, and the presence of key market players in the region. North America, especially the United States, has one of the highest incidences of cerebrovascular diseases such as strokes and aneurysms, which drives the demand for neurovascular interventions. The availability of cutting-edge medical technologies and the presence of highly skilled professionals further enhance the growth prospects in this region.

Additionally, North America has a well-established reimbursement framework for neurovascular treatments, making it more accessible for patients to undergo these life-saving procedures. With an increasing focus on improving patient outcomes and advancing minimally invasive treatments, the North American region is expected to continue leading the neurovascular catheters market.

Competitive Landscape and Leading Companies

The neurovascular catheters market is highly competitive, with several key players dominating the landscape. Leading companies such as Medtronic, Boston Scientific, Johnson & Johnson, and Stryker Corporation have extensive portfolios of neurovascular devices and are continually innovating to meet the growing demand for advanced, minimally invasive solutions. These companies invest heavily in research and development to enhance the performance and safety of their products. Moreover, strategic mergers and acquisitions (M&A) are common as companies seek to expand their product offerings and enter new markets.

Competitive strategies in the market include technological advancements, strategic partnerships with hospitals and healthcare providers, and regulatory approvals for new devices. As the demand for neurovascular treatments continues to rise, these companies are positioning themselves to lead the market through innovation, operational efficiency, and an increased focus on patient-centric solutions. The competitive landscape is expected to remain dynamic, with new entrants and collaborations shaping the future of the neurovascular catheters market.

List of Leading Companies:

• Medtronic
• Johnson & Johnson (Cordis)
• Boston Scientific
• Terumo Corporation
• Stryker Corporation
• Abbott Laboratories
• Asahi Intecc Co., Ltd.
• Cook Medical
• Penumbra, Inc.
• NeuroTherapia, Inc.
• MicroVention, Inc.
• Lepu Medical
• Becton, Dickinson and Company
• Endotronix, Inc.
• Vascular Solutions, Inc.

Recent Developments:

• Medtronic recently launched its Horizon™ Thrombectomy Catheter for stroke management, aiming to improve patient outcomes in thrombectomy procedures.
• Boston Scientific announced its acquisition of Vertiflex, a leader in neurovascular devices, strengthening its position in neurovascular treatments.
• Penumbra, Inc. received FDA approval for its Jet 7 Xtra Flex aspiration catheter, designed to enhance the efficiency of thrombectomy procedures in stroke patients.
• Terumo Corporation expanded its neurovascular portfolio with the introduction of the RayCATH™ thrombectomy catheter, enhancing its offering for acute ischemic stroke treatment.
• Stryker Corporation launched the Flowtriever® device to improve thrombus aspiration in neurovascular procedures, advancing treatment options for patients with stroke and embolisms.

Report Scope: